A detailed history of New York State Common Retirement Fund transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 13,625 shares of STRO stock, worth $47,006. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,625
Previous 13,625 -0.0%
Holding current value
$47,006
Previous $40,000 17.5%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$2.92 - $5.33 $604 - $1,103
207 Added 1.54%
13,625 $40,000
Q1 2024

May 07, 2024

SELL
$3.27 - $5.65 $722 - $1,248
-221 Reduced 1.62%
13,418 $76,000
Q4 2023

Feb 01, 2024

SELL
$2.07 - $4.54 $242 - $531
-117 Reduced 0.85%
13,639 $59,000
Q3 2023

Nov 07, 2023

BUY
$3.29 - $4.9 $845 - $1,259
257 Added 1.9%
13,756 $48,000
Q2 2023

Aug 07, 2023

SELL
$4.25 - $5.88 $293 - $405
-69 Reduced 0.51%
13,499 $63,000
Q1 2023

May 02, 2023

SELL
$4.48 - $8.45 $79,856 - $150,621
-17,825 Reduced 56.78%
13,568 $63,000
Q4 2022

Jan 30, 2023

BUY
$5.41 - $8.08 $66,386 - $99,149
12,271 Added 64.17%
31,393 $254,000
Q3 2022

Nov 08, 2022

BUY
$5.17 - $7.11 $553 - $760
107 Added 0.56%
19,122 $106,000
Q2 2022

Aug 04, 2022

SELL
$3.41 - $8.95 $41,816 - $109,753
-12,263 Reduced 39.21%
19,015 $99,000
Q4 2021

Feb 02, 2022

SELL
$14.25 - $23.53 $1,068 - $1,764
-75 Reduced 0.24%
31,278 $465,000
Q3 2021

Nov 02, 2021

SELL
$16.88 - $22.38 $103,204 - $136,831
-6,114 Reduced 16.32%
31,353 $592,000
Q2 2021

Aug 02, 2021

BUY
$18.03 - $23.82 $251,825 - $332,693
13,967 Added 59.43%
37,467 $697,000
Q4 2020

Feb 08, 2021

BUY
$10.16 - $23.98 $127,000 - $299,750
12,500 Added 113.64%
23,500 $510,000
Q2 2019

Aug 09, 2019

BUY
$9.69 - $12.23 $95,931 - $121,077
9,900 Added 900.0%
11,000 $125,000
Q1 2019

May 08, 2019

BUY
$8.8 - $11.87 $9,680 - $13,057
1,100 New
1,100 $13,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $180M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.